{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T19:31:54Z","timestamp":1771011114844,"version":"3.50.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"9120","license":[{"start":{"date-parts":[[1998,6,1]],"date-time":"1998-06-01T00:00:00Z","timestamp":896659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[1998,6]]},"DOI":"10.1016\/s0140-6736(97)12445-x","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T13:37:16Z","timestamp":1027604236000},"page":"1905-1910","source":"Crossref","is-referenced-by-count":349,"title":["Randomised trial of interferon \u03b1-2a as adjuvant therapy in resected primary melanoma thicker than 1\u00b75 mm without clinically detectable node metastases"],"prefix":"10.1016","volume":"351","author":[{"given":"Jean Jacques","family":"Grob","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Dreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"de la Salmoniere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Delaunay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier","family":"Cupissol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Guillot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Souteyrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Sassolas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Cesarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Lionnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Lok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude","family":"Chastang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Jacques","family":"Bonerandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(97)12445-X_bib1","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/1097-0142(19950115)75:2+<726::AID-CNCR2820751417>3.0.CO;2-R","article-title":"The role of adjuvant therapy in melanoma management","volume":"75","author":"Barth","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/S0140-6736(97)12445-X_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/JCO.1996.14.1.1","article-title":"Finally, a successful adjuvant therapy for high-risk melanoma","volume":"14","author":"Balch","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0140-6736(97)12445-X_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JCO.1996.14.1.7","article-title":"Interferon alfa-2 b adjuvant therapy of high risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684","volume":"14","author":"Kirkwood","year":"1996","journal-title":"J Clin Oncol"},{"issue":"suppl 7","key":"10.1016\/S0140-6736(97)12445-X_bib4","first-page":"83","article-title":"Studies of interferons in the therapy of melanoma","volume":"18","author":"Kirkwood","year":"1991","journal-title":"Semin Oncol"},{"key":"10.1016\/S0140-6736(97)12445-X_bib5","first-page":"410","article-title":"Evaluation of efficacy of adjuvant therapy with IFN-alpha 2a in melanoma patients with regional node metastases","volume":"14","author":"Cascinelli","year":"1995","journal-title":"ProcAm Sac Clin Oncol"},{"key":"10.1016\/S0140-6736(97)12445-X_bib6","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1200\/JCO.1995.13.11.2776","article-title":"Randomized, surgical adjuvant clinical trial of recombinant interferon alfa 2 a in selected patients with malignant melanoma","volume":"13","author":"Creagan","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0140-6736(97)12445-X_bib7","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1002\/1097-0142(19921001)70:7<1917::AID-CNCR2820700719>3.0.CO;2-5","article-title":"The annual risk of melanoma progression","volume":"70","author":"Slinghuff","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/S0140-6736(97)12445-X_bib8","series-title":"Cutaneous melanoma","first-page":"165","article-title":"An analysis of prognostic factors in 8500 patients with cutaneous melanoma","author":"Balch","year":"1992"},{"key":"10.1016\/S0140-6736(97)12445-X_bib9","series-title":"The design and analysis of sequential clinical trials","author":"Whitehead","year":"1992"},{"key":"10.1016\/S0140-6736(97)12445-X_bib10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"JASA"},{"key":"10.1016\/S0140-6736(97)12445-X_bib11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Sac (B)"},{"key":"10.1016\/S0140-6736(97)12445-X_bib12","series-title":"Cutaneous melanoma","first-page":"188","article-title":"A comparison of prognostic factors worldwide","author":"Balch","year":"1992"},{"key":"10.1016\/S0140-6736(97)12445-X_bib13","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(94)90030-2","article-title":"Results of adjuvant interferon study in WHO melanoma programme","volume":"343","author":"Cascinelli","year":"1994","journal-title":"Lancet"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014067369712445X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014067369712445X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T23:37:58Z","timestamp":1733269078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014067369712445X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,6]]},"references-count":13,"journal-issue":{"issue":"9120","published-print":{"date-parts":[[1998,6]]}},"alternative-id":["S014067369712445X"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(97)12445-x","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[1998,6]]}}}